Plasma concentrations in humans are reported in the range 220 M for GSH [1, 13, 14], and 0.140.34 M for GSSG [13, 14, 42]
This cascade drives interferon responses and the production of pro-inflammatory cytokines, ultimately reshaping the tumor microenvironment 65,66
GHK-Cu Regulatory Status GHK-Cu is not an FDA-approved drug
Individuals most likely to benefit include: Those with pernicious anemia People with gastrointestinal disorders (e.g., Crohns disease, celiac disease, chronic gastritis) Patients following bariatric (weight loss) surgery Older adults with absorption difficulties Strict vegetarians or vegans at risk for deficiency People taking medications that can decrease vitamin B12 levels Laboratory testing usually confirms B12 deficiency before starting injections
Schedule Your Consultation In research and use, GHK-Cu is associated with: Results vary, and GHK-Cu is most effective as part of a complete skin, hair, or recovery plan rather than a stand-alone fix
10.1186/1916-0216-43-20 J Otolaryngol Head Neck Surg